688180 君实生物
2025/06 - 中期
人民币(K¥)
与去年末期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)

非流动资产
长期股权投资260,87416.81%223,334242,576492,639457,791
投资性房地产0--0000
固定资产2,176,612-4.58%2,281,0612,431,8561,894,6311,882,276
在建工程1,987,7836.95%1,858,5641,325,3571,043,664801,934
无形资产500,520-4.01%521,405546,965316,094264,980
商誉0--0000
其他非流动资产1,965,04421.77%1,613,7791,225,0391,594,9841,783,039
6,890,8326.04%6,498,1435,771,7925,342,0125,190,020

流动资产
货币资金3,005,88420.13%2,502,2013,788,1936,030,7413,506,638
应收账款526,3513.24%509,817483,226238,1861,293,122
存货556,902-4.72%584,471538,053599,021484,601
其他流动资产695,6181.21%687,328761,603348,536560,530
4,784,75611.69%4,283,8175,571,0757,216,4845,844,891

流动负债
短期借款937,73738.29%678,106452,435351,3620
应付票据0--04,6720466
应付帐款1,033,217-16.18%1,232,6841,381,1451,057,4571,584,703
其他流动负债997,78371.11%583,134600,145357,492416,285
2,968,73819.04%2,493,9242,438,3981,766,3112,001,453
流动资产净值1,816,0181.46%1,789,8933,132,6785,450,1733,843,438
资产总额减流动负债8,706,8505.05%8,288,0378,904,46910,792,1869,033,458

非流动负债
长期借款1,780,355-10.07%1,979,6801,195,794839,582490,000
应付债券0--0000
其他非流动负债534,37842.04%376,227388,065176,143227,084
2,314,734-1.75%2,355,9071,583,8591,015,725717,084

总权益
    实收股本1,026,6904.16%985,690985,690982,872910,757
    储备项目5,345,6459.66%4,874,7346,165,5348,500,7557,034,339
股东权益6,372,3348.74%5,860,4247,151,2249,483,6267,945,095
非控股权益19,782-72.41%71,705169,386292,834371,279